WNT9B
Basic information
Region (hg38): 17:46833201-46886730
Previous symbols: [ "WNT15" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WNT9B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 16 | ||||
missense | 25 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 16 | 11 |
Variants in WNT9B
This is a list of pathogenic ClinVar variants found in the WNT9B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-46851642-C-A | Uncertain significance (Nov 19, 2022) | |||
17-46851643-G-GC | Renal dysplasia;Chronic kidney disease;Renal hypoplasia | Likely pathogenic (Jun 19, 2021) | ||
17-46872524-G-A | Likely benign (Oct 29, 2023) | |||
17-46872574-G-A | Benign (Nov 05, 2021) | |||
17-46872574-G-C | WNT9B-related disorder | Likely benign (Oct 28, 2019) | ||
17-46872579-A-G | Benign (Jan 22, 2024) | |||
17-46872583-C-T | Benign/Likely benign (Oct 29, 2023) | |||
17-46872601-G-A | WNT9B-related disorder | Likely benign (Mar 31, 2023) | ||
17-46872607-C-T | Benign (Jan 23, 2024) | |||
17-46872618-T-G | Uncertain significance (Oct 17, 2022) | |||
17-46872623-C-T | Inborn genetic diseases | Uncertain significance (Apr 01, 2024) | ||
17-46872627-G-A | Uncertain significance (Jul 10, 2023) | |||
17-46872653-C-T | Inborn genetic diseases | Uncertain significance (Oct 25, 2023) | ||
17-46872673-G-A | Likely benign (Oct 04, 2022) | |||
17-46872720-G-A | WNT9B-related disorder | Benign (Aug 24, 2023) | ||
17-46872729-G-A | WNT9B-related disorder | Likely benign (Mar 21, 2022) | ||
17-46872756-T-C | WNT9B-related disorder | Benign (Jan 31, 2024) | ||
17-46872759-G-T | Inborn genetic diseases | Uncertain significance (Jul 12, 2023) | ||
17-46875094-G-C | WNT9B-related disorder | Likely benign (Sep 19, 2019) | ||
17-46875141-C-T | Likely benign (Sep 11, 2023) | |||
17-46875142-G-A | Benign (Dec 02, 2023) | |||
17-46875155-C-A | Uncertain significance (Jul 16, 2021) | |||
17-46875164-G-A | Uncertain significance (Aug 17, 2023) | |||
17-46875165-G-T | Benign (Jan 29, 2024) | |||
17-46875171-C-G | Uncertain significance (Feb 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WNT9B | protein_coding | protein_coding | ENST00000290015 | 4 | 53530 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.541 | 0.456 | 125718 | 0 | 6 | 125724 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.803 | 182 | 215 | 0.846 | 0.0000142 | 2256 |
Missense in Polyphen | 76 | 102.92 | 0.73845 | 998 | ||
Synonymous | -0.114 | 98 | 96.6 | 1.01 | 0.00000616 | 766 |
Loss of Function | 2.49 | 2 | 10.8 | 0.185 | 4.58e-7 | 138 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000547 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000902 | 0.00000879 |
Middle Eastern | 0.0000547 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors (PubMed:20093360). Functions in the canonical Wnt/beta-catenin signaling pathway. Plays a role in cranofacial development and is required for normal fusion of the palate during embryonic development (By similarity). {ECO:0000250|UniProtKB:O35468, ECO:0000305|PubMed:20093360}.;
- Pathway
- Gastric cancer - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Breast cancer - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Basal cell carcinoma - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Wnt signaling pathway - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);ESC Pluripotency Pathways;Wnt Signaling Pathway and Pluripotency;Wnt Signaling in Kidney Disease;EMT transition in Colorectal Cancer;Signaling by GPCR;Signaling by WNT;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;WNT ligand biogenesis and trafficking;GPCR signaling-G alpha i;Wnt Canonical;Wnt Mammals
(Consensus)
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- loftool
- 0.459
- rvis_EVS
- 0.53
- rvis_percentile_EVS
- 80.96
Haploinsufficiency Scores
- pHI
- 0.121
- hipred
- Y
- hipred_score
- 0.532
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.677
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wnt9b
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; embryo phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; growth/size/body region phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- branching involved in ureteric bud morphogenesis;in utero embryonic development;regulation of protein phosphorylation;regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;cell-cell signaling;multicellular organism development;cellular response to starvation;regulation of asymmetric cell division;regulation of signaling receptor activity;Wnt signaling pathway;neuron differentiation;male genitalia development;response to retinoic acid;regulation of tube size;positive regulation of catalytic activity;cell fate commitment;embryonic cranial skeleton morphogenesis;roof of mouth development;canonical Wnt signaling pathway;Wnt signaling pathway, planar cell polarity pathway;uterus morphogenesis;cornea development in camera-type eye;cellular response to retinoic acid;kidney rudiment formation;mesenchymal stem cell maintenance involved in nephron morphogenesis;collecting duct development;establishment of planar polarity involved in nephron morphogenesis;metanephric tubule formation;mesonephric duct formation;negative regulation of stem cell population maintenance;midbrain dopaminergic neuron differentiation;non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation
- Cellular component
- extracellular region;extracellular space
- Molecular function
- frizzled binding;co-receptor binding;receptor ligand activity